HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Beiersdorf CEO Heidenreich Affirms: “We’re On The Right Track”

This article was originally published in The Rose Sheet

Executive Summary

Beiersdorf is seeing early signs that its new business strategy and streamlining efforts are paying off. The firm’s first-quarter sales increased 6.9% to €1.53 billion, with strong performances from its NIVEA and Eucerin brands. Emerging markets were a source of growth, and new CEO Stefan Heidenreich vows to mend the firm’s leaky China business.

You may also be interested in...



Beiersdorf CEO Signs Five-Year Contract Following Strong 2013

Beiersdorf CEO Stefan Heidenreich has signed a new five-year contract extending his tenure through 2019, the Hamburg, Germany-based firm announces in conjunction with the release of its preliminary Q4/full year 2013 results. Sales rose more than 7% organically to more than $8 billion, though the results on a nominal sales basis were weighted down by currency effects.

P&G Might Need To Split, Divest To Stay Competitive – Analysts

P&G could benefit from splitting into two businesses, divesting its premium fragrances or pulling out of core personal care product categories, experts suggest. Financial services firm UBS says, “While P&G is stepping up its spending, cutting costs and accelerating new product launches – so are its competitors.”

P&G Might Need To Split, Divest To Stay Competitive – Analysts

P&G could benefit from splitting into two businesses, divesting its premium fragrances or pulling out of core personal care product categories, experts suggest. Financial services firm UBS says, “While P&G is stepping up its spending, cutting costs and accelerating new product launches – so are its competitors.”

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018086

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel